Member Info for johnlaycock

Must be an error price is still c7p to buy/sell

The 147k is a buy but showing as a sell.

Confirmation!

I suspect conformation of specialist commissioning will come very soon....no CEX would say he is 100% sure it will happen unless he is indeed 100% sure it will happen.

There is always a transitionary period between a company developing a product and then commercialising it. We are in this period but very close to beginning the commercial roll out. Patience will be rewarded.

Guy, if you want to hear about the company's income then I suggest you listen to the CFO's presentation pre Christmas. You will also hear him say month outgoings are currently 327k when the R&D refund is factored in.

Hold firm, the promised good news is just around the corner.

Monthly spend is 327k when the R&D refund is factored in.

I contacted the NICE project team today for an update on timescales and whilst they obviously didnt give me much detail, the PM emailed to say that they would be updating stakeholders and the timelines 'soon'. This chimes with what Mr Cheek said in his pre Christmas update. Watch this space then....

Roger - the company have always stated the market in the UK is c8million pa, not 5 million.

Brilliant find. A potential game changer....looking forward to an exciting week!

Perhaps Roger when you do receive news from God, you can ask him for his take on whether we will hit 20p+ in the next few weeks?

I admire your optimism but realistically if we hold 20p plus in the next few weeks that would be a good start !

Re FDA partners and contracts etc , James said in the presentation news would forthcoming on this in December or very early next year (ie 2024) so we could have news this week on the FDA plan and route etc.

An excellent summary Stephen, looks to be an exciting few days/weeks ahead. I hope NICE gets its act in gear for both tests asap.

Would be great to hear of confirmation of specialist commissioning next week. That would propell the SP for sure.

Ask now at 8.75p.

Volume looking good.

Thanks Stephen. Momentum seems to be there and a national roll out seems imminent. Coupled with international sales and news on the FDA route, the next few weeks look to be very exciting. Plus we have been promised news on the NICE approval of the stroke test. A single figure SP will soon be a distant memory.

Start the engine!

KSS is Kent, Surrey and Sussex with Medway NHS Trust as the lead partner here.